Invention Grant
- Patent Title: Benzoimidazol-1,2-yl amides as Kv7 channel activators
-
Application No.: US17127231Application Date: 2020-12-18
-
Publication No.: US11834418B2Publication Date: 2023-12-05
- Inventor: Lynn Resnick , George T. Topalov , Justin K. Belardi , James S. Hale , Scott S. Harried , Charles A. Flentge , David A. Mareska
- Applicant: BIOHAVEN THERAPEUTICS LTD.
- Applicant Address: US CT New Haven
- Assignee: Biohaven Therapeutics Ltd.
- Current Assignee: Biohaven Therapeutics Ltd.
- Current Assignee Address: VG Tortola
- Main IPC: C07D235/30
- IPC: C07D235/30 ; C07D413/04 ; C07D401/04 ; C07D405/12 ; C07D403/04 ; C07D401/12
Abstract:
Optionally substituted benzoimidazol-1,2-yl amides, such as compounds of Formula 1 or Formula 2, can be used to treat disorders associated with a Kv7 potassium channel activator. Compositions, medicaments, and dosage forms related to the treatment are also disclosed herein.
Public/Granted literature
- US20210188782A1 BENZOIMIDAZOL-1,2-YL AMIDES AS Kv7 CHANNEL ACTIVATORS Public/Granted day:2021-06-24
Information query
